What is the difference between Busonid 32 mcg and Busonid 64 mcg?
In the realm of allergic and immune-mediated diseases, the topic Busonid It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. What is the difference between Busonid 32 mcg and Busonid 64 mcg?, offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Understand the difference between Busonid 32 mcg and 64 mcg.
A common question in allergology and immunology clinics concerns the different presentations of medications prescribed for the treatment of inflammatory diseases of the airways. In the case of the nasal corticosteroid Busonid, whose active ingredient is budesonide, the main difference between the 32 microgram (mcg) and 64 microgram versions lies strictly in the concentration of the drug per dose.
The 32 mcg version delivers a lower dosage of inhaled corticosteroid, making it highly recommended for children. Children, due to their smaller body surface area and more delicate airways, often require lower concentrations to achieve adequate clinical control of symptoms, avoiding the use of excessive doses. On the other hand, the 64 mcg presentation offers twice the concentration and is commonly used in adult patients whose conditions require greater therapeutic potency to stabilize nasal symptoms.
It is very common for patients to be apprehensive about the prolonged use of corticosteroids. However, it is worth noting that nasal corticosteroids act topically and have a very high affinity for the nasal mucosa, where they are retained. Due to the reduced microgram dosage and its pharmacokinetics, the medication exhibits minimal systemic absorption.
This means that, when used correctly as directed by a doctor, nasal corticosteroids do not suppress the hypothalamic-pituitary-adrenal axis and do not interfere with the body's natural production of cortisol. For this reason, long-term treatments with nasal budesonide are considered safe, allowing for continuous control of conditions such as allergic rhinitis without the risk of serious systemic side effects.
Important note: This content is for educational and informational purposes only and should not, under any circumstances, replace consultation, diagnosis, or individualized prescription with a specialist physician.
Developments in Evidence-Based Medicine: Pharmacokinetics and Safety of Corticosteroids
The consolidated guidelines of Evidence-Based Medicine (GINA, ARIA, and Allergy and Endocrinology consensus) establish a strict distinction between the... topical/inhaled corticosteroids — which act locally on the respiratory or cutaneous mucosa with minimal systemic bioavailability and constitute the safe basis for chronic anti-inflammatory control — and the Systemic corticosteroids (oral or injectable depot corticosteroids, such as the combination of betamethasone dipropionate and disodium phosphate)Injectable depot formulations maintain prolonged release for weeks, promoting suppression of the hypothalamic-pituitary-adrenal axis (risk of secondary adrenal insufficiency), hyperglycemia, hypertension, fluid retention, bone demineralization, subcapsular cataracts, and immunosuppression, and should not be used as maintenance therapy for rhinitis, asthma, or urticaria.
💎 Diamond Plan — Knowing exactly which medications you react to provides lifelong peace of mind. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.
Nasal Irrigation, Safe Topical Sprays, and Desensitizing Immunotherapy
Environmental hygiene measures in the bedroom — waterproofing of mattresses and pillows, solar ventilation, and removal of dust reservoirs — go hand in hand with the allergy test and the vaccine for rhinitis individualized. When indicated by the specialist, the allergy vaccine It reduces nasal congestion in a lasting way and prevents the progression to recurrent sinusitis and bronchial hyperreactivity.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond PlanBrazil Without Allergies brings the same high standard of care from its clinics to your home, with telemedicine consultations and a more accessible path to immunotherapy. Knowing exactly which medications you react to provides lifelong peace of mind.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to Busonid It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seeking evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established options for specialized allergy and immunology care whenever indicated—ensures clinical safety and lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




